Limited Review for June 30, 2014
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended June 30, 2014.14-08-2014
Limited Review for June 30, 2014
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended June 30, 2014.Financial Results for June 30, 2014
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended June 30, 2014.Shareholding Pattern For June 30, 2014
Lincoln Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.Board recommends Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended the payment of Dividend of Rs. 0.60/- per equity share (@ 6%) of face value of Rs. 10/- each of the Company for the year 2013-14 subject to approval of the shareholders in the Annual General Meeting.Financial Results for March 31, 2014 (Audited)
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended March 31, 2014.Board to consider Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2014, to approve audited financial results for the quarter / year ended March 31, 2014 and for recommending dividend, if any.Shareholding Pattern for March 31, 2014
Lincoln Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.Results Press Release
Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2013.Limited Review for Dec 31, 2013
Lincoln Pharmaceuticals Ltd has informed BSE about the Limited Review Report for the period ended December 31, 2013.